Agnieszka Dzikiewicz‐Krawczyk

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

Agnieszka Dzikiewicz‐Krawczyk, Klaartje Kok, Izabella Ślęzak-Prochazka et al. · Leukemia · 2017 · 62 citations · Full text

Oncogenic Myc-mir-150-myb Network, Tumor Biology, Lymphoid Neoplasia +8

miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3

Magdalena Żurawek, Agnieszka Dzikiewicz‐Krawczyk, Katarzyna Iżykowska et al. · Diabetes Research and Clinical Practice · 2018 · 41 citations

Type 1, Autoimmune Disease, Diabetes +8

The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth

Fubiao Niu, Marta Kazimierska, Ilja M. Nolte et al. · Cancers · 2020 · 30 citations · Full text

Immunology, Pathology, Mir-26b-5p/kpna2 Axis +17

Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding

Agnieszka Dzikiewicz‐Krawczyk, Anna Macieja, Ewa Mały et al. · Journal of Hematology & Oncology · 2014 · 26 citations · Full text

MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma

Ye Yuan, Fubiao Niu, Ilja M. Nolte et al. · Cellular Physiology and Biochemistry · 2018 · 26 citations · Full text